ArticleScientific reports2026
Leveraging medical imaging and deep learning for diagnosis of breast cancer using histopathological images.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, breast cancer is one the life-threatening diseases among women. Breast histopathological image (HI) investigation is the most effective method applied for the recognition of cancer malignancy. Manual breast HI investigation is, still, time-consuming, abstract, and susceptible to human errors. Computer-aided diagnosis (CAD) became a possible and popular solution for medicinal image investigation owing to current developments in computer memory and power. Still, the CAD methods performance required to be enhanced to apply for practical reasons. In recent times, deep learning (DL) like convolution neural networks (CNN) have proved reliable in identifying BC targets from pathological images. This paper proposes a Leveraging Medical Imaging for Early Breast Cancer Detection Using Deep Leaning (LMIBCD-DL). The LMIBCD-DL approach presents a reliable tool for supporting automated breast cancer diagnosis in medical applications. Initially, the LMIBCD-DL method applies wiener filtering (WF) for the image preprocessing step to effectively reduce noise while preserving important tissue structures. For feature extractors, the squeeze-and-excitation ResNet (SE-ResNet) model is employed to capture rich and discriminative representations from complex histopathological patterns. Finally, the bi-directional long short-term memory (BiLSTM) is utilized for the BC detection process. The comparative results demonstrated a superior accuracy value of 98.72% over the existing methodologies under dissimilar measures and the BreakHis dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.